tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Amicus Therapeutics (DE:AM6)
:AM6
Germany Market
AM6
Amicus
RESEARCH TOOLSreports
Advertisement

Amicus (AM6) Stock News & Sentiment

Compare
0 Followers
Amicus Stock Upgraded to Buy: DMX-200’s Potential and Galafold’s Growth Drive Investment Opportunity
Premium
Ratings
Amicus Stock Upgraded to Buy: DMX-200’s Potential and Galafold’s Growth Drive Investment Opportunity
1M ago
FOLD
Positive Outlook for Amicus Therapeutics Amid Legal Developments and Patent Confidence
Premium
Ratings
Positive Outlook for Amicus Therapeutics Amid Legal Developments and Patent Confidence
1M ago
FOLD
Amicus Therapeutics’ Pompe Disease Study: A Potential Game-Changer for Investors
Premium
Company Announcements
Amicus Therapeutics’ Pompe Disease Study: A Potential Game-Changer for Investors
2M ago
FOLD
Amicus Therapeutics’ Global Study on Pompe Disease: A Potential Game-Changer
Premium
Company Announcements
Amicus Therapeutics’ Global Study on Pompe Disease: A Potential Game-Changer
2M ago
FOLD
Amicus Therapeutics’ Global Study on Pompe Disease: A Potential Game-Changer
Premium
Company Announcements
Amicus Therapeutics’ Global Study on Pompe Disease: A Potential Game-Changer
2M ago
FOLD
Amicus’s Strong Performance and Growth Potential Drive Buy Rating
Premium
Ratings
Amicus’s Strong Performance and Growth Potential Drive Buy Rating
3M ago
FOLD
Amicus Therapeutics Reports Strong Growth Amid Strategic Advances
Premium
Company Announcements
Amicus Therapeutics Reports Strong Growth Amid Strategic Advances
3M ago
FOLD
More DE:AM6 News >

AM6 News on the Web

FDA Extends Review of DNLI's Hunter Syndrome Drug by Three Months
Zacks
Neutral
Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease
Zacks
Bullish
All You Need to Know About Amicus Therapeutics (FOLD) Rating Upgrade to Strong Buy
Zacks
Bullish
SKYE Stock Plunges 60% as Obesity Candidate Misses Key Phase II Goal
Zacks
Neutral
Zacks.com featured highlights include Amicus Therapeutics, Micron Technology and General Dynamics
Zacks
Neutral
Bet on These 3 Stocks With Upgraded Broker Ratings for Solid Returns
Zacks
Bullish
Can Galafold Drive Amicus' Growth Through the Rest of 2025?
Zacks
Neutral
Why Amicus Therapeutics, Inc.’s (FOLD) Stock Is Up 5.70%
AAII
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:AM6’s Media Buzz Sentiment?
Currently, no data Available
What is DE:AM6’s weekly average amount of articles?
Currently, no data Available
What is DE:AM6’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
DHRDanaher
VSTMVerastem
NNVCNanoViricides
BEAMBeam Therapeutics
BSXBoston Scientific
Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing